Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death.

Molecular cell | Sep 3, 2001

http://www.ncbi.nlm.nih.gov/pubmed/11583623

X chromosome-linked inhibitor of apoptosis (XIAP) is an endogenous inhibitor of caspase-3, -7, and -9. Smac/DIABLO, an inhibitor of XIAP, is released from mitochondria upon receiving apoptotic stimuli and binds to the BIR2 and BIR3 domains of XIAP, thereby inhibiting its caspase-inhibitory activity. Here we report that a serine protease called HtrA2/Omi is released from mitochondria and inhibits the function of XIAP by direct binding in a similar way to Smac. Moreover, when overexpressed extramitochondrially, HtrA2 induces atypical cell death, which is neither accompanied by a significant increase in caspase activity nor inhibited by caspase inhibitors, including XIAP. A catalytically inactive mutant of HtrA2, however, does not induce cell death. In short, HtrA2 is a Smac-like inhibitor of IAP activity with a serine protease-dependent cell death-inducing activity.

Pubmed ID: 11583623 RIS Download

Mesh terms: Amino Acid Sequence | Apoptosis | Carrier Proteins | Caspase Inhibitors | Caspases | Cell Fractionation | Cell Line | Cloning, Molecular | Genes, Reporter | Humans | Intracellular Signaling Peptides and Proteins | Microscopy, Fluorescence | Mitochondria | Mitochondrial Proteins | Protein Binding | Protein Transport | Proteins | Recombinant Fusion Proteins | Serine Endopeptidases | Ultraviolet Rays | X-Linked Inhibitor of Apoptosis Protein

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.